Inhibitors of 5-lipoxygenase: a therapeutic potential yet to be fully realized?

This publication has 78 references indexed in Scilit:

• CGS 26529: The biological profile of a novel, orally active 5-lipoxygenase inhibitor with an extended duration of action
  Inflammation Research, 1995
• Naphthalenic Lignan Lactones as Selective, Nonredox 5-Lipoxygenase Inhibitors. Synthesis and Biological Activity of (Methoxyalkyl)thiazole and Methoxytetrahydropyran Hybrids
  Journal of Medicinal Chemistry, 1994
• Conformational analysis of 5-lipoxygenase inhibitors: role of the substituents in chiral recognition and on the active conformations of the (methoxyalkyl)thiazole and methoxytetrahydropyran series
  Journal of Medicinal Chemistry, 1994
• 5‐lipoxygenase‐activating protein is an arachidonate binding protein
  FEBS Letters, 1993
• A23187-induced translocation of 5-lipoxygenase in osteosarcoma cells.
  Journal of Cell Biology, 1992
• A new class of leukotriene biosynthesis inhibitors: The development of ((4-(4-chlorophenyl)-1-(4-(2-quinolinylmethoxy)phenyl)butyl)thio)acetic acid, L-674,636
  Bioorganic & Medicinal Chemistry Letters, 1991
• A double-blind vehicle-controlled study of R 68 151 in psoriasis: A topical 5-lipoxygenase inhibitor
  Journal of the American Academy of Dermatology, 1990
• Topical anti-inflammatory activity of DuP 654, a 2-substituted 1-naphthol
  Inflammation Research, 1989
• Effects of a thromboxane synthetase inhibitor (OKY-046) and a lipoxygenase inhibitor (AA-861) on bronchial responsiveness to acetylcholine in asthmatic subjects.
  Thorax, 1986
• Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes
  Nature, 1980